Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Collard

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
The European Respiratory Journal|December 11, 2012
Prevalence and prognosis of unclassifiable interstitial lung diseaseChristopher J Ryerson, Thomas H Urbania, Luca Richeldi, et al.
Respiratory Research|November 22, 2012
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosisSeung-Ick Cha, Christopher J Ryerson, Joyce S Lee, et al.
The Lancet. Respiratory Medicine|April 20, 2015
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trialsMichael T Durheim, Harold R Collard, Rhonda S Roberts, et al.
Annals of the American Thoracic Society|August 29, 2014
Open-access biorepository for idiopathic pulmonary fibrosis. The way forwardEric S White, Kevin K Brown, Harold R Collard, et al.
Respiratory Medicine|August 26, 2015
Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteriaDeborah Assayag, Eunice J Kim, Brett M Elicker, et al.
Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.
Chest|February 9, 2013
Radiographic fibrosis score predicts survival in hypersensitivity pneumonitisJoshua J Mooney, Brett M Elicker, Thomas H Urbania, et al.
The Lancet. Respiratory Medicine|August 4, 2018
Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trialsMargaret Neighbors, Christopher R Cabanski, Thirumalai R Ramalingam, et al.
BMJ Open Respiratory Research|October 12, 2017
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung diseaseKevin R Flaherty, Kevin K Brown, Athol U Wells, et al.
Plos One|July 1, 2016
miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary FibrosisSupparerk Disayabutr, Eun Kyung Kim, Seung-Ick Cha, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
The European Respiratory Journal|December 11, 2012
Prevalence and prognosis of unclassifiable interstitial lung diseaseChristopher J Ryerson, Thomas H Urbania, Luca Richeldi, et al.
Respiratory Research|November 22, 2012
Cleaved cytokeratin-18 is a mechanistically informative biomarker in idiopathic pulmonary fibrosisSeung-Ick Cha, Christopher J Ryerson, Joyce S Lee, et al.
The Lancet. Respiratory Medicine|April 20, 2015
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trialsMichael T Durheim, Harold R Collard, Rhonda S Roberts, et al.
Annals of the American Thoracic Society|August 29, 2014
Open-access biorepository for idiopathic pulmonary fibrosis. The way forwardEric S White, Kevin K Brown, Harold R Collard, et al.
Respiratory Medicine|August 26, 2015
Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteriaDeborah Assayag, Eunice J Kim, Brett M Elicker, et al.
Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.
Chest|February 9, 2013
Radiographic fibrosis score predicts survival in hypersensitivity pneumonitisJoshua J Mooney, Brett M Elicker, Thomas H Urbania, et al.
The Lancet. Respiratory Medicine|August 4, 2018
Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trialsMargaret Neighbors, Christopher R Cabanski, Thirumalai R Ramalingam, et al.
BMJ Open Respiratory Research|October 12, 2017
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung diseaseKevin R Flaherty, Kevin K Brown, Athol U Wells, et al.
Plos One|July 1, 2016
miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary FibrosisSupparerk Disayabutr, Eun Kyung Kim, Seung-Ick Cha, et al.
Pageof 25